Recent research indicates that lncRNA NEAT1, which is regulated by the EGFR pathway, contributes to glioblastoma tumorigenesis and progression through the WNT/β -Catenin pathway by scaffolding enhancer of zeste 2 polycomb repressive complex 2 subunit, offering potentially new therapeutic directions in glioblastoma (13). This evidence concerns the gene EGFR and glioblastoma.